{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:03:07Z","timestamp":1792728187284,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008273","name":"Novartis Foundation for Sustainable Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008273","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.rmed.2025.108587","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T17:07:20Z","timestamp":1765818440000},"page":"108587","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Evolution and factors associated with presenteeism in severe asthma after treatment with biologics"],"prefix":"10.1016","volume":"251","author":[{"given":"Justine","family":"Subocz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Stoup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7516-4670","authenticated-orcid":false,"given":"Jonathan","family":"Giovannelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Bourdin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Guilleminault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Devouassoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Bonniaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Gicquello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Taill\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naji","family":"Khayath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amel","family":"Boudjemaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne-Marie","family":"Perotin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Hennegrave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Chabrol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Rolland-Debord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Verhille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Just","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6229-2075","authenticated-orcid":false,"given":"C\u00e9cile","family":"Chenivesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2025.108587_bib1","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","volume":"43","author":"Chung","year":"2014","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2025.108587_bib2","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00765-2017","article-title":"\"I have lost in every facet of my life\": the hidden burden of severe asthma","volume":"50","author":"Foster","year":"2017","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2025.108587_bib3","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.jaip.2018.12.029","article-title":"The burden of severe asthma in France: a case-control study using a medical claims database","volume":"7","author":"Bourdin","year":"2019","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.rmed.2025.108587_bib4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12995-024-00406-9","article-title":"Quality of life and work functionality in severe asthma patients: the impact of biological therapies","volume":"19","author":"Leso","year":"2024","journal-title":"J. Occup. Med. Toxicol."},{"key":"10.1016\/j.rmed.2025.108587_bib5","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.jval.2017.05.008","article-title":"Estimating the effect and economic impact of absenteeism, presenteeism, and work environment-related problems on reductions in productivity from a managerial perspective","volume":"20","author":"Str\u00f6mberg","year":"2017","journal-title":"Value Health"},{"key":"10.1016\/j.rmed.2025.108587_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40733-016-0029-3","article-title":"Asthma costs and social impact","volume":"3","author":"Nunes","year":"2017","journal-title":"Asthma Res Pract."},{"key":"10.1016\/j.rmed.2025.108587_bib7","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1067\/mai.2003.1449","article-title":"A comprehensive study of the direct and indirect costs of adult asthma","volume":"111","author":"Cisternas","year":"2003","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2025.108587_bib8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1183\/09031936.02.00232001","article-title":"Costs of asthma are correlated with severity: a 1-yr prospective study","volume":"19","author":"Godard","year":"2002","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2025.108587_bib9","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/cea.13153","article-title":"Working while unwell: workplace impairment in people with severe asthma","volume":"48","author":"Hiles","year":"2018","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.rmed.2025.108587_bib10","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1080\/02770903.2018.1499035","article-title":"Economic impact of severe asthma in Spain: Multicentre observational longitudinal study","volume":"56","author":"Melero Moreno","year":"2019","journal-title":"J. Asthma"},{"key":"10.1016\/j.rmed.2025.108587_bib11","doi-asserted-by":"crossref","first-page":"611","DOI":"10.2147\/JAA.S401445","article-title":"Symptom burden, health status, and productivity in patients with uncontrolled and controlled severe asthma in NOVELTY","volume":"16","author":"Ding","year":"2023","journal-title":"J. Asthma Allergy"},{"key":"10.1016\/j.rmed.2025.108587_bib12","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.anai.2022.12.018","article-title":"A comparison of the effectiveness of biologic therapies for asthma: a systematic review and network meta-analysis","volume":"130","author":"Pitre","year":"2023","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.rmed.2025.108587_bib13","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0238-2023","article-title":"Biologic agents licensed for severe asthma: a systematic review and meta-analysis of randomised controlled trials","volume":"33","author":"Kyriakopoulos","year":"2024","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.rmed.2025.108587_bib14","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.rmed.2018.06.021","article-title":"Real-world safety and efficacy of omalizumab in patients with severe allergic asthma: a long-term post-marketing study in Japan","volume":"141","author":"Adachi","year":"2018","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2025.108587_bib15","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s41669-019-0117-4","article-title":"Economic impact and clinical outcomes of omalizumab Add-On therapy for patients with severe persistent asthma: a real-world study","volume":"3","author":"Entrenas Costa","year":"2019","journal-title":"Pharmacoecon Open"},{"key":"10.1016\/j.rmed.2025.108587_bib16","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/crj.13474","article-title":"Mepolizumab improves work productivity, activity limitation, symptoms, and rescue medication use in severe eosinophilic asthma","volume":"16","author":"Albers","year":"2022","journal-title":"Clin Respir J"},{"key":"10.1016\/j.rmed.2025.108587_bib17","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1080\/02770903.2023.2196563","article-title":"Anti-IL-5\/5Ra biologics improve work productivity and activity in severe asthma: a RAPSODI registry-based cohort study","volume":"60","author":"van der Valk","year":"2023","journal-title":"J. Asthma"},{"key":"10.1016\/j.rmed.2025.108587_bib18","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","article-title":"The validity and reproducibility of a work productivity and activity impairment instrument","volume":"4","author":"Reilly","year":"1993","journal-title":"Pharmacoeconomics"},{"issue":"3","key":"10.1016\/j.rmed.2025.108587_bib19","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1378\/chest.93.3.580","article-title":"Evaluation of clinical methods for rating dyspnea","volume":"93","author":"Mahler","year":"1988","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.rmed.2025.108587_bib20","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S1081-1206(10)60532-7","article-title":"Assessing the validity of self-reported medication adherence among inner-city asthmatic adults: the medication adherence report scale for asthma","volume":"103","author":"Cohen","year":"2009","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"4","key":"10.1016\/j.rmed.2025.108587_bib21","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1034\/j.1399-3003.1999.14d29.x","article-title":"Development and validation of a questionnaire to measure asthma control","volume":"14","author":"Juniper","year":"1999","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2025.108587_bib22","series-title":"Manual for the State-Trait Anxiety Inventory","author":"Spielberger","year":"1983"},{"issue":"1","key":"10.1016\/j.rmed.2025.108587_bib23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/coa.12315","article-title":"French adaptation and validation of the sino-nasal outcome test-22: a prospective cohort study on quality of life among 422 subjects","volume":"40","author":"de Dorlodot","year":"2015","journal-title":"Clin. Otolaryngol."},{"key":"10.1016\/j.rmed.2025.108587_bib24","doi-asserted-by":"crossref","first-page":"839","DOI":"10.3109\/02770903.2014.922190","article-title":"Hyperventilation in asthma: a validation study of the nijmegen Questionnaire--NQ","volume":"51","author":"Grammatopoulou","year":"2014","journal-title":"J. Asthma"},{"issue":"2","key":"10.1016\/j.rmed.2025.108587_bib25","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/thx.47.2.76","article-title":"Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials","volume":"47","author":"Juniper","year":"1992","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2025.108587_bib26","first-page":"211","article-title":"A review of methods to measure health-related productivity loss","volume":"13","author":"Mattke","year":"2007","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.rmed.2025.108587_bib27","series-title":"A Language and Environment for Statistical Computing","year":"2008"},{"key":"10.1016\/j.rmed.2025.108587_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2020.101965","article-title":"Rapid effect of benralizumab for severe asthma with chronic rhinosinusitis with nasal polyps","volume":"64","author":"Matsuno","year":"2020","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.rmed.2025.108587_bib29","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1159\/000507996","article-title":"A comprehensive evaluation of mepolizumab effectiveness in a real-life setting","volume":"18","author":"Cameli","year":"2020","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.rmed.2025.108587_bib30","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1016\/j.jaip.2021.08.004","article-title":"Benralizumab effectiveness in severe eosinophilic asthma with and without chronic rhinosinusitis with nasal polyps: a real-world multicenter study","volume":"9","author":"Nolasco","year":"2021","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.rmed.2025.108587_bib31","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2147\/JAA.S328988","article-title":"Short-term evaluation of dupilumab effects in patients with severe asthma and nasal polyposis","volume":"14","author":"Pelaia","year":"2021","journal-title":"J. Asthma Allergy"},{"key":"10.1016\/j.rmed.2025.108587_bib32","doi-asserted-by":"crossref","first-page":"5883","DOI":"10.3390\/jcm13195883","article-title":"Real-world efficacy of biological therapies in severe asthma: a focus on small airways","volume":"13","author":"Ora","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.rmed.2025.108587_bib33","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1152\/japplphysiol.00329.2007","article-title":"Lung function in adults with stable but severe asthma: air trapping and incomplete reversal of obstruction with bronchodilation","volume":"104","author":"Sorkness","year":"2008","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.rmed.2025.108587_bib34","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3109\/02770903.2013.789058","article-title":"Lung volume abnormalities and its correlation to spirometric and demographic variables in adult asthma","volume":"50","author":"Jain","year":"2013","journal-title":"J. Asthma"},{"key":"10.1016\/j.rmed.2025.108587_bib35","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/oemed-2016-104014","article-title":"Factors associated with work productivity among people with COPD: birmingham COPD cohort","volume":"74","author":"Rai","year":"2017","journal-title":"Occup. Environ. Med."},{"key":"10.1016\/j.rmed.2025.108587_bib36","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0015-2017","article-title":"Mechanisms, measurement and management of exertional dyspnoea in asthma: number 5 in the series \"Exertional dyspnoea\"","volume":"26","author":"Weatherald","year":"2017","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.rmed.2025.108587_bib37","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.rmed.2016.06.003","article-title":"Activity limitation and exertional dyspnea in adult asthmatic patients: what do we know?","volume":"117","author":"Vermeulen","year":"2016","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2025.108587_bib38","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2500\/aap.2011.32.3501","article-title":"Impact of exercise-related respiratory symptoms in adults with asthma: exercise-induced bronchospasm landmark national survey","volume":"32","author":"Parsons","year":"2011","journal-title":"Allergy Asthma Proc."},{"key":"10.1016\/j.rmed.2025.108587_bib39","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1080\/02770903.2016.1242138","article-title":"Relationship between the sensation of activity limitation and the results of functional assessment in asthma patients","volume":"54","author":"Vermeulen","year":"2017","journal-title":"J. Asthma"},{"key":"10.1016\/j.rmed.2025.108587_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2023.107276","article-title":"Severity and phenotypes of dyspnea in asthma: impact of comorbidities","author":"Bousso","year":"2023","journal-title":"Respir. Med."},{"issue":"4","key":"10.1016\/j.rmed.2025.108587_bib41","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1185\/030079907X178793","article-title":"Relationship of nasal congestion with sleep, mood, and productivity","volume":"23","author":"Stull","year":"2007","journal-title":"Curr. Med. Res. Opin."},{"issue":"1\u20132","key":"10.1016\/j.rmed.2025.108587_bib42","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s13554-014-0019-z","article-title":"Healthcare resource utilization in patients receiving omalizumab for allergic asthma in a real-world setting","volume":"4","author":"Braunstahl","year":"2014","journal-title":"Biol. Ther."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095461112500650X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095461112500650X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:30:24Z","timestamp":1777595424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095461112500650X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":42,"alternative-id":["S095461112500650X"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108587","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evolution and factors associated with presenteeism in severe asthma after treatment with biologics","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108587","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108587"}}